Suchergebnisse - "Witjes, Han"

PubPharm (50)

1

Characterizing the exposure-response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma

enthalten in: CPT: pharmacometrics & systems pharmacology | 2023

von Connarn, J. | Witjes, H. | van Zutphen-van Geffen, M. | +5

2

Characterizing the exposure–response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma

enthalten in: CPT: Pharmacometrics & Systems Pharmacology | 2023

von Connarn, J. | Witjes, H. | van Zutphen‐van Geffen, M. | +5

3

Mobocertinib Dose Rationale in Patients with Metastatic NSCLC with EGFR Exon 20 Insertions : Exposure-Response Analyses of a Pivotal Phase I/II Study

enthalten in: Clinical pharmacology and therapeutics | 2022

von Gupta, N. | Largajolli, A. | Witjes, H. | +5

4

Mobocertinib Dose Rationale in Patients with Metastatic NSCLC with EGFR Exon 20 Insertions : Exposure–Response Analyses of a Pivotal Phase I/II Study

enthalten in: Clinical Pharmacology & Therapeutics | 2022

von Gupta, N. | Largajolli, A. | Witjes, H. | +5

5

Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia

enthalten in: AJOG global reports | 2021

von Brookfield, K. | Galadanci, H. | Du, L. | +6

6

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis

enthalten in: EBioMedicine | 2021

von Maas, B. | Lommerse, J. | Plock, N. | +25

7

Meta-Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis : Supporting Evidence of Risankizumab Superiority

enthalten in: Clinical pharmacology and therapeutics | 2020

von Witjes, H. | Khatri, A. | Diderichsen, P. | +2

8

Meta‐Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis : Supporting Evidence of Risankizumab Superiority

enthalten in: Clinical Pharmacology & Therapeutics | 2020

von Witjes, H. | Khatri, A. | Diderichsen, P. | +2

9

Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia : A Population Pharmacokinetic Exposure-Response Modeling and Simulation Study

enthalten in: Journal of clinical pharmacology | 2019

von Du, L. | Wenning, L. | Carvalho, B. | +11

10

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling : Implications for Initial Neonatal Dosing

enthalten in: CPT: pharmacometrics & systems pharmacology | 2019

von Lommerse, J. | Clarke, D. | Kerbusch, T. | +8

1
2
3
4
5
Nächster »
[5]